700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)Mylene Perreault |
||
Pfizer, USA | ||
Biography | ||
Mylene Perreault is an in vivo physiologist/pharmacologist with extensive drug discovery experience for type 2 diabetes and obesity programs. She had been Team leader and biology lead on several pre-clinical projects and proven experience as co-team leader on multiple clinical assets. She has also managed a group of BS/MS/PhD/Post-doctoral fellow and recognized as a very good communicator with excellent ability to work in a team environment. She had done her PhD in Physiology-Endocrinology from Université Laval in 2002 | ||
Research Interest | ||
Drug Discovery In Vivo Drug Development Pharmacology Assay Development Pharmaceutical Industry Biotechnology Type 2 Diabetes Project Management in vivo physiology | ||
Publications | ||
Mengmeng Wang, David Defranco, Katherine Wright, Shakey Quazi, Jianqing Chen, Jennifer Spencer-Pierce, Iman Zaghloul, Roger Pak, Ramin Darvair, Aadithya Krishnan, Mylene Perreault, Lei Sun, Josef Ozer and Xin Xu Research Article: JBB/Vol.4.5 069-077 (2012) |
||
Global Speakers in the subjectGlobal Experts in the subject |